Putnam Investments’s Alimera Sciences ALIM Stock Holding History

Putnam Investments’s Portfolio ALIM Stock Details ALIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-15,866	Closed	-$1.1M	–	1553
2015 Q2	$1.1M	Buy	+15,866	New	+$1.09M	﹤0.01%	1206

Other funds holding ALIM

Scale Management Foster City, California $359M AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return

Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Putnam Investments's ALIM Position: Q3 2015 in Review

Putnam Investments sold out of Alimera Sciences (ALIM) in Q3 2015, closing a stake of 15,866 shares — an estimated $1.1M sold.

Putnam Investments first reported a position in ALIM in Q2 2015 and held it in 1 quarter. The position peaked at $1.1M in Q2 2015. 63 funds tracked by Wall St. Rank hold ALIM as of Q3 2015.

Putnam Investments reported no remaining Alimera Sciences position as of Q3 2015 after selling out during the quarter.
Putnam Investments sold 15,866 Alimera Sciences shares in Q3 2015, an estimated $1.1M.
Putnam Investments first reported a position in Alimera Sciences in Q2 2015 and held it in 1 quarter.
Putnam Investments's Alimera Sciences position peaked at $1.1M in Q2 2015.
63 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2015.

Based on Putnam Investments's 13F filing for Q3 2015, filed 16 Nov 2015.